H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 133 Citations 60,675 561 World Ranking 907 National Ranking 548

Research.com Recognitions

Awards & Achievements

1996 - Member of the National Academy of Medicine (NAM)

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

Prostate cancer, Prostatectomy, Prostate, Surgery and Prostate-specific antigen are his primary areas of study. The various areas that Peter T. Scardino examines in his Prostate cancer study include Stage, Nomogram and Urology. His biological study spans a wide range of topics, including Salvage therapy, Radiation therapy, Radiology, Metastasis and Proportional hazards model.

His Prostate study combines topics from a wide range of disciplines, such as Adenocarcinoma, Biopsy, Pathology and Gynecology. His Surgery research includes themes of Positive Surgical Margin, Radical retropubic prostatectomy and Risk factor. His Prostate-specific antigen research is multidisciplinary, relying on both Natural history and Cohort study.

His most cited work include:

  • Integrative genomic profiling of human prostate cancer (2553 citations)
  • Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi- institutional update (1687 citations)
  • The Molecular Taxonomy of Primary Prostate Cancer (1426 citations)

What are the main themes of his work throughout his whole career to date?

Peter T. Scardino focuses on Prostate cancer, Prostatectomy, Internal medicine, Urology and Prostate. Prostate cancer is a primary field of his research addressed under Cancer. His research integrates issues of Stage, Radiation therapy, Surgery and Nomogram in his study of Prostatectomy.

His research in Surgery intersects with topics in Positive Surgical Margin and Lymph node. His Urology study integrates concerns from other disciplines, such as Androgen deprivation therapy, Erectile dysfunction and Radical retropubic prostatectomy. His Prostate research focuses on subjects like Cancer research, which are linked to Androgen receptor.

He most often published in these fields:

  • Prostate cancer (69.09%)
  • Prostatectomy (51.55%)
  • Internal medicine (35.87%)

What were the highlights of his more recent work (between 2013-2021)?

  • Prostate cancer (69.09%)
  • Prostatectomy (51.55%)
  • Internal medicine (35.87%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Prostate cancer, Prostatectomy, Internal medicine, Oncology and Urology. His Prostate cancer research is multidisciplinary, incorporating perspectives in Biopsy, Prostate and Surgery. His studies in Surgery integrate themes in fields like Medical physics and Nomogram.

Peter T. Scardino has included themes like Proportional hazards model, Androgen deprivation therapy, Radiation therapy and Lymph node in his Prostatectomy study. His biological study spans a wide range of topics, including Prostate cancer screening, Metastasis, Multimodal therapy and PCA3. His Urology research incorporates elements of Prospective cohort study and Erectile dysfunction, Erectile function.

Between 2013 and 2021, his most popular works were:

  • The Molecular Taxonomy of Primary Prostate Cancer (1426 citations)
  • Organoid cultures derived from patients with advanced prostate cancer (705 citations)
  • Copy number alteration burden predicts prostate cancer relapse (188 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

The scientist’s investigation covers issues in Prostate cancer, Prostatectomy, Internal medicine, Prostate and Oncology. His Prostate cancer study combines topics from a wide range of disciplines, such as Biopsy, Surgery and Urology. His study in Prostatectomy is interdisciplinary in nature, drawing from both Androgen deprivation therapy, Prospective cohort study, Disease and Urinary incontinence.

His Prostate study combines topics in areas such as Stage, Cancer research, Magnetic resonance imaging and Androgen receptor. The study incorporates disciplines such as Odds ratio, Life expectancy, Cause of death and Comorbidity in addition to Oncology. The various areas that Peter T. Scardino examines in his Cancer study include Overdiagnosis and Intensive care medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Integrative genomic profiling of human prostate cancer

Barry S. Taylor;Nikolaus Schultz;Haley Hieronymus;Anuradha Gopalan.
Cancer Cell (2010)

3286 Citations

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi- institutional update

Alan W. Partin;Michael W. Kattan;Eric N. P. Subong;Patrick C. Walsh.
JAMA (1997)

2403 Citations

Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men

William J. Catalona;Jerome P. Richie;Frederick R. Ahmann;M'Liss A. Hudson.
The Journal of Urology (1994)

2187 Citations

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

William C Huang;Andrew S Levey;Angel M Serio;Mark Snyder.
Lancet Oncology (2006)

1692 Citations

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

W.J. Catalona;A.W. Partin;K.M. Slawin;M.K. Brawer.
JAMA (1998)

1541 Citations

A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer

M.W. Kattan;J.A. Eastham;A.M.F. Stapleton;T.M. Wheeler.
Journal of the National Cancer Institute (1998)

1407 Citations

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally.
Cell (2015)

1243 Citations

Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer

Brett S. Carver;Caren Chapinski;John Wongvipat;Haley Hieronymus.
Cancer Cell (2011)

1022 Citations

Variations in Morbidity after Radical Prostatectomy

Colin B. Begg;Elyn R. Riedel;Peter B. Bach;Michael W. Kattan.
The New England Journal of Medicine (2002)

925 Citations

Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

Andrew J. Stephenson;Peter T. Scardino;Michael W. Kattan;Thomas M. Pisansky.
Journal of Clinical Oncology (2007)

920 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter T. Scardino

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 346

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 345

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 337

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 328

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 287

Peter R. Carroll

Peter R. Carroll

University of California, San Francisco

Publications: 277

Mark A. Rubin

Mark A. Rubin

University of Bern

Publications: 265

Jonathan I. Epstein

Jonathan I. Epstein

Johns Hopkins University

Publications: 257

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 248

Alan W. Partin

Alan W. Partin

Johns Hopkins University School of Medicine

Publications: 234

Michael W. Kattan

Michael W. Kattan

Cleveland Clinic

Publications: 212

Hans Lilja

Hans Lilja

Memorial Sloan Kettering Cancer Center

Publications: 208

Hartwig Huland

Hartwig Huland

Universität Hamburg

Publications: 200

Matthew R. Cooperberg

Matthew R. Cooperberg

University of California, San Francisco

Publications: 195

Eric A. Klein

Eric A. Klein

Cleveland Clinic

Publications: 194

Hashim U. Ahmed

Hashim U. Ahmed

Imperial College Healthcare NHS Trust

Publications: 185

Something went wrong. Please try again later.